Mahadevia Ankit Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$1.41M

Insider Activity of Mahadevia Ankit

Biography of Mahadevia Ankit

No biography is available at this moment.

2025-08-28SaleSpero Therapeutics, Inc.
SPRO
director
6,572
0.0115%
$1.97$12,947+16.5%
2025-02-05SaleSpero Therapeutics, Inc.
SPRO
director
69,219
0.1315%
$0.78$53,991+150.86%
2024-08-27SaleSpero Therapeutics, Inc.
SPRO
director
5,912
0.0107%
$1.35$7,981-15.58%
2024-02-02SaleSpero Therapeutics, Inc.
SPRO
director
63,795
0.105%
$1.37$87,399-8.22%
2023-08-28SaleSpero Therapeutics, Inc.
SPRO
director
9,040
0.0172%
$1.26$11,390+11.51%
2023-02-03SaleSpero Therapeutics, Inc.
SPRO
CEO and President
12,286
0.0223%
$1.81$22,238-23.68%
2021-12-27SaleSpero Therapeutics, Inc.
SPRO
CEO and President
8,000
0.0264%
$14.58$116,666-86.67%
2020-11-04SaleSpero Therapeutics, Inc.
SPRO
CEO and President
14,740
0.056%
$14.43$212,670+16.65%
2020-11-03SaleSpero Therapeutics, Inc.
SPRO
CEO and President
4,274
0.0111%
$10.08$43,098+13.96%
2020-10-23SaleSpero Therapeutics, Inc.
SPRO
CEO and President
40
0.0001%
$10.07$403+12.62%
2020-10-14SaleSpero Therapeutics, Inc.
SPRO
CEO and President
210
0.0008%
$14.25$2,993+13.52%
2020-10-13SaleSpero Therapeutics, Inc.
SPRO
CEO and President
28,734
0.0761%
$10.09$289,978+10.77%
2020-09-08SaleSpero Therapeutics, Inc.
SPRO
CEO and President
1,548
0.0054%
$10.08$15,596+12.05%
2020-07-09SaleSpero Therapeutics, Inc.
SPRO
CEO and President
4,586
0.022%
$14.31$65,613+3.97%
2020-07-07SaleSpero Therapeutics, Inc.
SPRO
CEO and President
1,508
0.0051%
$10.08$15,194+3.1%
2020-06-25SaleSpero Therapeutics, Inc.
SPRO
CEO and President
5,284
0.0263%
$14.25$75,301+0.83%
2020-06-24SaleSpero Therapeutics, Inc.
SPRO
CEO and President
7,760
0.0379%
$14.28$110,839-1.76%
2020-06-23SaleSpero Therapeutics, Inc.
SPRO
CEO and President
16,090
0.0401%
$7.16$115,264-0.07%
2020-06-22SaleSpero Therapeutics, Inc.
SPRO
CEO and President
5,226
0.0129%
$7.15$37,365-1.14%
2018-07-06SaleSpero Therapeutics, Inc.
SPRO
See Remarks
3,200
0.0191%
$17.65$56,495-34.81%
Total: 21
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.